嘉 鼎 國 際 集 團 控 股 有 限 公 司 JIADING INTERNATIONAL GROUP HOLDINGS LIMITED 嘉 鼎 國 際 集 團 控 股 有 限 公 司 JIADING INTERNATIONAL GROUP HOLDINGS LIMITED （ 於 百 慕 達 註 冊 成 立 之 有 限 公 司 ） (Incorporated in Bermuda with limited liability) （ 於 百 慕 達 註 冊 成 立 之 有 限 公 司 ） (Incorporated in Bermuda with limited liability) （股份代號：08153） (Stock code: 08153) （股份代號：08153） (Stock code: 08153) CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE "STOCK EXCHANGE") GEM has been positioned as a market designed to accommodate s ...

香 港 交 易 及 結 算 所 有 限 公 司 及 香 港 聯 合 交 易 所 有 限 公 司（「聯交所」）對 本 公 告 之 內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示 概 不 就 本公告全部或任何部分內容而產生或因倚賴該等內容而引致之任何損失承擔 任 何 責 任。 JIADING INTERNATIONAL GROUP HOLDINGS LIMITED 嘉鼎國際集團控股有限公司 （股份 代號：08153） （於百慕達註冊成立之有限公司） 截至二零二五年三月三十一日止年度之全年業績公告 嘉 鼎 國 際 集 團 控 股 有 限 公 司（「本公司」）董 事（「董 事」）會（「董事會」）欣 然 宣 佈 本 公 司 及 其 附 屬 公 司 於 截 至 二 零 二 五 年 三 月 三 十 一 日 止 年 度 的 經 審 核 綜 合 業 績。 本 公 告 載 有 本 公 司 二 零 二 五 年 年 報 全 文，符 合 香 港 聯 合 交 易 所 有 限 公 司GEM 證 券 上 市 規 則（「GEM上市規則」）有 關 年 度 業 績 初 步 公 告 所 ...

Key Points - As of June 4, a total of 109 stocks reached their 52-week highs, with notable performers including 嘉鼎国际集团 (08153), 中国抗体－Ｂ (03681), and 升华兰德 (08106) achieving high rates of 37.84%, 32.89%, and 32.26% respectively [1] - The highest closing price among the top performers was 嘉鼎国际集团 at 0.405, while its peak price reached 0.510 [1] - 中国抗体－Ｂ closed at 2.850 with a peak of 2.990, and 升华兰德 closed at 0.142 with a peak of 0.164 [1] 52-Week High Rankings - 嘉鼎国际集团 (08153) had a high rate of 37.84% [1] - 中国抗体－Ｂ (03681) followed with a high rate of 32.89% [1] - 升华兰德 (08106) achieved a high rate of 32.26% [1] - Other notable stocks include 亿都（国际控股） with a high rate of 24.55% and 倍搏集团 with 23.59% [1] Additional Insights - The data indicates a strong performance in the market, with a significant number of stocks reaching new highs, suggesting potential bullish sentiment among investors [1] - The performance of these stocks may reflect broader trends in specific sectors, particularly in biotechnology and healthcare, as seen with the high rates of 中国抗体－Ｂ and 升华兰德 [1]

Financial Performance - The Group recorded a revenue of approximately HK$36.6 million for the six months ended 30 September 2024, representing a significant decrease of approximately 15.1% compared to HK$43.1 million in the preceding period[10]. - The loss for the Period was approximately HK$27.0 million, compared to a loss of approximately HK$8.0 million in the preceding period, mainly due to decreased gross profit margin and increased distribution costs and administrative expenses[11]. - The advertising services business generated revenue of approximately HK$34.8 million, a decrease of approximately 1.7% from HK$35.4 million in the preceding period, attributed to weak market sentiments[17]. - Zixing Health recorded a revenue of approximately HK$1.6 million, representing a decrease of approximately 50.0% compared to approximately HK$3.2 million in the preceding period[34][36]. - The total loss before income tax for the six months ended September 30, 2024, was HK$26,325,000, reflecting a significant decline in profitability compared to previous periods[156]. - Loss per share attributable to owners of the Company was HK$19.17, compared to HK$8.79 in the previous year, indicating a worsening loss per share[113]. - The company reported a significant decrease in revenue from the PRC, dropping to HK$1,778,000 from HK$7,713,000 in the previous year[171]. Expenses and Costs - Administrative expenses increased significantly by approximately 98.5% to approximately HK$26.2 million, up from approximately HK$13.2 million in the preceding period[35][37]. - The increase in loss was primarily attributed to a decrease in gross profit margin and a significant rise in distribution costs and administrative expenses[39][41]. - The Group's advertising segment reported a loss of HK$4,684,000, contributing to the overall financial performance challenges faced during this period[156]. - Employee benefit expenses increased to HK$3,596,000 in 2024 from HK$4,429,000 in 2023, with salaries and wages rising from HK$2,447,000 to HK$3,421,000[189]. - The company incurred finance costs of HK$1,017,000, contributing to the overall financial performance[186]. Cash Flow and Liquidity - The Group's cash and cash equivalents increased to approximately HK$27.3 million as of 30 September 2024, up from approximately HK$6.7 million as of 31 March 2024, primarily due to rights issue activities[44]. - Current assets decreased to HK$12,361,000 from HK$13,503,000 as of March 31, 2024, reflecting a decline in liquidity[116]. - Cash and cash equivalents at the end of the reporting period increased to HK$27,329,000 from HK$25,290,000, marking a net increase of HK$2,039,000[131]. - The company generated HK$24,315,000 from financing activities, down from HK$32,429,000 in the previous year, primarily due to a decrease in proceeds from borrowings[131]. Business Segments and Operations - The Group's new energy batteries segment recorded total revenue of approximately HK$0.1 million during the period, indicating ongoing development and internal adjustments in battery technology[21]. - No revenue was recorded from the sales of new energy off-road vehicles during the Period, as the Group is considering adjustments to its business model and actively redesigning off-road vehicles to enhance competitiveness[27][28]. - The Group has maintained four reportable operating segments: sales of health care products, sales of new energy off-road vehicles, sales of new energy batteries, and advertising[150]. - The Group plans to enhance product coverage and improve production processes through significant R&D investments[68]. Future Outlook and Strategy - The Group aims to capture business opportunities in the second half of the year by closely monitoring existing operations and deploying resources accordingly[18]. - Recent mainland policies encouraging financial support and operational subsidies are expected to generate revenue for the Group in the near future[29]. - The Group anticipates a clearer outlook for its advertising business in 2025 due to improving macroeconomic conditions[63]. - The new energy battery business is expected to benefit from the global transition to renewable energy, with China accounting for over half of the global electric vehicle market[64]. - The Group is optimistic about the future of new energy batteries, driven by the rapid increase in global demand for electric vehicles and renewable energy[75]. Share Capital and Corporate Governance - The Company proposed a share consolidation and capital reorganization, which was approved by shareholders and became effective on 21 May 2024[45][47]. - As of 30 September 2024, the Company's issued share capital was approximately HK$36,683, with 366,827,260 ordinary shares of par value HK$0.0001 each[46][48]. - The share option scheme allows for the issuance of 7,642,281 shares, with a mandate limit refreshed to 10% of the issued shares as of April 6, 2023[84][87]. - The company has complied with all code provisions of the Corporate Governance Code for the six months ended September 30, 2024[94]. - Mr. Li Guangying resigned as an executive Director effective August 7, 2024[94]. - Ms. Wang Dongmei resigned as a non-executive Director effective July 5, 2024[94]. Audit and Compliance - The Audit Committee reviewed the unaudited interim report for the six months ended September 30, 2024, confirming compliance with applicable accounting standards and GEM Listing Rules[105]. - The interim financial statements have been prepared in accordance with HKAS 34 and have not been audited but reviewed by the Company's audit committee[138]. - The accounting policies applied in the preparation of the interim financial statements are consistent with those used in the 2024 Annual Report, ensuring continuity in financial reporting[143].

Financial Performance - The Group recorded a revenue of approximately HK$36.6 million for the six months ended 30 September 2024, representing a significant decrease of approximately 15.1% compared to HK$43.1 million for the same period in 2023[13]. - The Group incurred a loss of approximately HK$27.0 million for the Period, compared to a loss of approximately HK$8.0 million in the preceding period, primarily due to a decrease in gross profit margin and a significant increase in distribution costs and administrative expenses[14]. - Loss before income tax increased to HK$26,325,000, compared to a loss of HK$7,806,000 in the same period last year, indicating a significant deterioration in financial performance[113]. - The total comprehensive expense for the period was HK$26,309,000, compared to HK$5,507,000 in the previous year, highlighting increased financial challenges[116]. - Loss per share attributable to owners of the Company was HK$19.17, compared to HK$8.79 in the previous year, indicating a worsening loss per share[116]. Revenue Breakdown - Revenue from the advertising services business was approximately HK$34.8 million, a decrease of approximately 1.7% from HK$35.4 million in the preceding period, attributed to weak market sentiments[20]. - Zixing Health recorded a revenue of approximately HK$1.6 million, a decrease of approximately 50.0% compared to approximately HK$3.2 million in the preceding period, primarily due to weak market sentiments[37]. - Revenue from external customers in Hong Kong was HK$34,826,000, a slight decrease from HK$35,369,000 in the previous year[174]. - The geographical revenue breakdown indicates that sales in the PRC dropped significantly from HK$7,713,000 to HK$1,778,000 year-over-year[174]. Expenses and Costs - The significant increase in distribution costs and administrative expenses contributed to the overall loss for the Period[14]. - The Group's administrative expenses increased significantly by approximately 98.5% to approximately HK$26.2 million, compared to approximately HK$13.2 million in the preceding period, mainly due to increased vehicle design and consultancy fees[40]. - Employee benefit expenses increased to HK$3,421,000 from HK$2,447,000, representing a rise of 39.7%[192]. - Total finance costs for the six months ended September 30, 2024, were HK$1,009,000, slightly down from HK$1,017,000 in 2023, a decrease of 0.8%[190]. Cash Flow and Liquidity - As of September 30, 2024, the Group had cash and cash equivalents of approximately HK$27.3 million, a significant increase from approximately HK$6.7 million as of March 31, 2024, due to rights issue activities[47]. - Net cash used in operating activities for the six months ended 30 September 2024 was HK$ (3,130,000), a significant improvement compared to HK$ (25,755,000) in the same period of 2023[134]. - Cash and cash equivalents at the end of the reporting period increased to HK$ 27,329,000 from HK$ 25,290,000 in the previous year[134]. - The Group's current ratio was approximately 1.9, lower than 2.7 as of March 31, 2024, but still considered acceptable for maintaining liquidity[47]. Capital and Financing Activities - The completion of the rights issue occurred on 26 September 2024, with net proceeds of approximately HK$25.8 million, which will be used for debt repayment, working capital, and expansion of various business segments[53][56]. - The intended allocation of the net proceeds includes HK$7.5 million for debt repayment, HK$3 million for advertising business working capital, and HK$3,300,000 for R&D of new energy off-road vehicles[56][57]. - The Group's outstanding borrowings increased to approximately HK$17.2 million from approximately HK$16.1 million as of March 31, 2024, primarily consisting of unsecured loans and promissory notes[47]. - Net cash generated from financing activities was HK$ 24,315,000, down from HK$ 32,429,000 in the previous year[134]. Business Segments and Strategy - The Group's principal activities include sales of health care products, new energy off-road vehicles, new energy batteries, and advertising services[138]. - The Group has four reportable operating segments: sales of health care products, sales of new energy off-road vehicles, sales of new energy batteries, and advertising[153]. - The Group plans to closely monitor operations in the advertising segment and allocate resources proportionately to capture business opportunities in the second half of the year[21]. - The Group aims to enhance its competitive edge by offering value-added services and annual advertising solutions across various media platforms[16]. Future Outlook - The Group anticipates a clearer outlook for its advertising business in 2025 due to improving macroeconomic conditions and market environment[66]. - The new energy battery business is expected to grow significantly, driven by increasing global demand for electric vehicles and renewable energy resources, particularly in China, which accounts for over half of the global electric vehicle market[67]. - The Group believes it is well-prepared to capitalize on growth opportunities in the new energy battery sector, driven by strong government support in China[73]. Corporate Governance and Compliance - The Company has complied with all corporate governance code provisions for the six months ended September 30, 2024[97]. - The Audit Committee reviewed the unaudited interim report and confirmed compliance with applicable accounting standards and GEM Listing Rules[108]. - The interim financial statements have been reviewed by the Company's audit committee but not audited[141]. Share Capital and Options - As of 30 September 2024, the company's issued share capital was approximately HK$36,683, with 366,827,260 ordinary shares of par value HK$0.0001 each[49][51]. - The share option scheme adopted on April 6, 2023, has a mandate limit refreshed to 10% of the issued shares, with 7,642,281 shares available for issue as of the report date[87]. - The total number of share options exercised during the period was 4,074,426 shares[93]. - The previous share option scheme was terminated on April 6, 2023, with movements detailed for the six months ended September 30, 2024[92].

Financial Performance - The Group recorded a revenue of approximately HK$112.7 million for the year ended 31 March 2024, representing an increase of 16.07% compared to approximately HK$97.1 million in the previous year[18]. - The loss for the Reporting Period amounted to approximately HK$16.1 million, a significant improvement from the loss of approximately HK$67.2 million in the last year[18]. - The loss attributable to owners of the Company for the Reporting Period was HK$21.1 million, compared to a net loss of approximately HK$67.2 million for the last corresponding period[18]. - The Group's loss for the year was approximately HK$16.1 million, a significant improvement from a loss of approximately HK$67.2 million in the previous year[19]. - The Group's revenue for the year ended March 31, 2024, was approximately HK$112.7 million, an increase of 16.07% from HK$97.1 million in the previous year, primarily driven by the advertising services segment[39]. - The loss attributable to the owners of the Company decreased to approximately HK$21.1 million from HK$67.2 million in the last reporting year, resulting in a loss per share of HK24.85 cents versus HK117.1 cents[68]. - The gross profit margin improved significantly to 21.74%, up from 13.9% in the previous year, mainly due to increased contributions from new business[69]. Revenue Segments - The advertising services segment generated approximately HK$66.3 million, a decrease of 22.0% compared to approximately HK$85.0 million in the prior year, primarily due to challenges in the Hong Kong advertising market[21]. - The new energy battery segment generated revenue of approximately HK$2.3 million, while sales of new energy off-road vehicles reached HK$10.5 million and health care products sales amounted to HK$33.7 million, both of which were new revenue streams for the Group[36]. - Advertising services revenue decreased to approximately HK$66.3 million, down 22.1% from HK$85.0 million, due to increased digital consumption and a shift towards online channels[42]. - The sales of new energy off-road vehicles generated HK$10.4 million during the review period, following the acquisition of Weishi (Shenzhen) on June 26, 2023[48]. - Revenue from new energy battery sales was approximately HK$2.3 million, with significant advancements in graphene battery technology noted[50]. - The health care products segment generated approximately HK$33.7 million in revenue, following the acquisition of Zixing Health on August 30, 2023[51]. Business Strategy and Outlook - The Group plans to integrate its new energy battery business with the new energy off-road vehicle business to reduce costs and enhance market competitiveness[24]. - The management is optimistic about the business environment for the new energy battery segment, driven by favorable green energy policies and the recovery of the domestic economy in China[29]. - The Group is committed to exploring new business areas to support long-term growth amidst a challenging global economic environment[29]. - The Group aims to enhance product quality and innovate in the new energy battery technology to drive future revenue growth[23]. - The management anticipates better performance for the Chinese economy in 2024, supported by favorable government policies promoting new energy industries[58]. - The Group aims to maintain a stable operation in the advertising segment while capturing business opportunities as the economy recovers in 2024[45]. - The Group's five largest customers accounted for 42.9% of total revenue for the year, with the largest customer contributing 14.3%[164]. Financial Position and Liquidity - The Group raised approximately HK$29.8 million through the placing of 305,691,261 new ordinary shares at HK$0.10 per share, aimed at debt repayment and business expansion[57]. - As of March 31, 2024, the Group had cash and cash equivalents of approximately HK$6.7 million, down from HK$16.0 million as of March 31, 2023, due to high demand for financial resources[78]. - The current ratio improved to 2.71 from 2.52 as of March 31, 2023, indicating a reasonable liquidity level[78]. - The Group's outstanding borrowings were approximately HK$16.1 million, a decrease of 38.54% from approximately HK$26.2 million as of March 31, 2023[79][82]. - The Group's gearing ratio was 10.1% as of March 31, 2024, down from 20.1% as of March 31, 2023, reflecting a reduction in borrowings during the year[79][82]. - Total finance costs decreased by 45.6% to approximately HK$1.9 million, primarily due to reduced interest payments on borrowings[77]. Operational Efficiency and Cost Management - The Group's effective cost control measures and customer loyalty helped mitigate the negative impacts of the pandemic and weak market sentiments[36]. - Administrative expenses rose by 4.11% to approximately HK$32.9 million, primarily due to R&D costs and recruitment for new health product business[70]. - Impairment loss on trade receivables and other receivables decreased significantly to approximately HK$6.8 million from HK$43.0 million in the previous year[71]. - Total staff costs, including key management remuneration, increased to approximately HK$9.5 million in 2024 from HK$6.9 million in 2023, reflecting an increase in employee headcount to 42[87][90]. - The Group is committed to enhancing operational efficiency through improvements in lighting and air conditioning systems[143]. Governance and Risk Management - The company has appointed several experienced directors to strengthen its governance and strategic direction, including Mr. Luo and Ms. Liu[121][125]. - The management acknowledges the operational dependency on third-party service providers and engages only reputed providers to mitigate risks[138]. - The company has identified various financial risks, which are disclosed in note 6 to the consolidated financial statements[136]. - The Group has been actively monitoring the performance of third-party service providers to mitigate operational risks[144]. - The company has faced principal risks and uncertainties, which are detailed in the "Management Discussion and Analysis" section of the report[135]. Environmental Responsibility - The company recognizes its responsibility to protect the environment and aims to promote efficient use of resources and adopt green technologies for emission reduction[137]. - The company is actively monitoring its environmental impact and seeks to minimize it through various initiatives[137]. - The company aims to identify energy efficiency opportunities by measuring and recording energy consumption intensity[137]. Shareholder Information - The Group did not recommend the payment of a dividend for the year ended March 31, 2024, consistent with the previous year[147][154]. - The Group has no distributable reserves as of March 31, 2024, as required by the Companies Act of Bermuda[161]. - The Group did not make any charitable donations for the year ended March 31, 2024[162]. - There were no purchases, redemptions, or sales of the Company's listed securities during the year[160]. - No substantial shareholders or other persons had interests or short positions in shares or underlying shares that required disclosure as of March 31, 2024[198]. - None of the Directors or substantial shareholders engaged in any business that competes with the Group during the year ended March 31, 2024[199]. - The Company has adopted a share option scheme as an incentive for Directors and eligible employees[186]. - The remuneration of Directors and senior management is determined with reference to market rates and individual contributions[185].

Financial Performance - Jiading International Group Holdings Limited announced its audited consolidated results for the year ending March 31, 2024[2]. - The Group recorded a revenue of approximately HK$112.7 million for the year ended 31 March 2024, representing an increase of 16.07% compared to approximately HK$97.1 million in the previous year[22]. - The Group reported a loss of approximately HK$16.1 million for the reporting period, a significant improvement from a loss of approximately HK$67.2 million in the last year[22]. - Revenue increased by 16.07% to approximately HK$15.6 million compared to HK$97.1 million in the previous year, with a loss attributable to owners of approximately HK$21.1 million, down from HK$67.2 million[72]. - Gross profit margin improved significantly to 21.74%, up from 13.9% in the previous year, primarily due to increased contributions from new business[73]. - The Group's revenue for the year ended 31 March 2024 was approximately HK$112.7 million, representing a 16.07% increase from HK$97.1 million in the previous year, primarily driven by the Advertising Services Segment in Hong Kong[40]. - The Group's revenue from the five largest customers accounted for 42.9% of total revenue for the year, with the largest customer contributing 14.3%[168]. Business Operations and Strategy - The report aims to provide relevant information regarding the company's operations and financial status[11]. - The Group is exploring innovative designs and technologies in the new energy battery segment to improve product quality and increase revenue in the coming year[27]. - The Group plans to monitor the advertising market closely and implement strategic cost controls while seeking new business opportunities[26]. - The Group aims to inject driving power for long-term growth by exploring new business areas in response to the improving domestic economy in the PRC[33]. - The Group's strategic plan includes a focus on technology development in graphene batteries, enhancing product design, safety, and recharging capabilities[54]. - The Group aims to integrate its new energy battery business with the new energy off-road vehicle business to reduce costs and enhance market competitiveness[53]. - The Group's investment in the health industry is expected to contribute positively to its long-term growth, capitalizing on the increased global focus on daily health care due to the COVID-19 pandemic[55]. Acquisitions and Investments - The Group acquired Weishi (Shenzhen) New Energy Technology Development Co., Ltd. on 26 June 2023, which specializes in new energy off-road vehicles, aiming to integrate this business with its new energy battery operations[28]. - The Group also acquired 51% of Zixing Health Technology (Shenzhen) Co. Ltd. on 30 August 2023, focusing on health care products utilizing advanced technologies[32]. - The acquisition of Zixing Health on August 30, 2023, is expected to contribute approximately HK$33.7 million in sales from health products, including small molecule peptide supplements[59]. - The acquisition of 51% equity interest in Zixing Health Technology for RMB5.1 million was completed on 30 August 2023, aimed at tapping into the growing healthcare products market in China[92]. Financial Health and Risks - Impairment losses on trade receivables decreased significantly to approximately HK$6.8 million from HK$43.0 million in the previous year, indicating improved financial health[75]. - The Group's administrative expenses increased by 4.11% to approximately HK$32.9 million, reflecting investments in expanding operations and recruiting additional personnel for new health product initiatives[74]. - Total finance costs decreased by 45.6% to approximately HK$1.9 million, down from HK$3.4 million, due to reduced interest payments on borrowings[81]. - Cash and cash equivalents decreased to approximately HK$6.7 million from HK$16.0 million, attributed to high demand for financial resources for operations and strategic investments[82]. - Outstanding borrowings decreased by 38.54% to approximately HK$16.1 million from HK$26.1 million, resulting in a gearing ratio of 10.1%, down from 20.1%[83]. - The Group's financial risks have been disclosed in note 6 to the consolidated financial statements[140][146]. Corporate Governance and Compliance - The board of directors collectively accepts full responsibility for the accuracy and completeness of the report[9]. - The company is required to comply with the GEM Listing Rules of the Stock Exchange of Hong Kong Limited[4]. - The company has adopted a share option scheme as an incentive for Directors and eligible employees[190]. - The emoluments of Directors and senior management are determined with reference to market rates and individual performance[189]. - The company has received annual confirmations of independence from all Independent Non-Executive Directors as of the report date[180]. - The Group has no unexpired service contracts for Directors that are not determinable within one year without compensation[182]. Market Outlook - The GDP of the PRC grew by 5.2% in 2023, indicating a positive business environment and better market opportunities in the second half of 2024[21]. - The demand for green technologies and products is expected to grow strongly due to rising energy prices and favorable green energy policies in the PRC[33]. - The Group anticipates improved prospects for the advertising business in 2024 due to better macroeconomic conditions and increased advertising budgets from clients[66]. - The Chinese economy is expected to perform better in 2024, supported by government policies promoting new energy industries and boosting domestic demand[62]. Shareholder Information - As of March 31, 2024, Mr. Mou Zhongwei holds 153,500,000 shares, representing approximately 8.36% of the total shareholding[197]. - The total number of issued shares as of March 31, 2024, is 1,834,136,305 shares[199]. - Ms. Wang Dongmei holds 9,926,000 shares, which is approximately 0.54% of the total shareholding[197]. - Mr. Li Guangying holds 6,000,000 shares, representing approximately 0.32% of the total shareholding[197]. Dividends and Reserves - The Group did not recommend the payment of a dividend for the year ended March 31, 2024, consistent with the previous year[151][158]. - The Group has no distributable reserves as of March 31, 2024, as required by the Companies Act of Bermuda[165].

Financial Performance - For the six months ended September 30, 2023, the net cash used in operating activities was HK$25,755,000, compared to HK$14,745,000 for the same period in 2022, indicating an increase in cash outflow [40]. - The total comprehensive income for the period was HK$31,099,000, a significant increase from the previous period's loss of HK$8,215,000 [12]. - The company recorded a loss for the period of HK$6,737,000, which is a decrease from the loss of HK$7,050,000 in the previous period, indicating a slight improvement in performance [3]. - The company reported a loss before income tax of HK$6,863,000 for the six months ended September 30, 2023 [67]. - The Group recorded a loss of approximately HK$8.0 million for the Period, a slight increase from the loss of approximately HK$7.1 million in the Preceding Period, mainly due to a decrease in gross profit margin and an increase in administrative expenses [130]. - The Group's total comprehensive expenses for the Period were approximately HK$5.5 million, compared to approximately HK$11.8 million in the Preceding Period [144]. Cash and Liquidity - Cash and cash equivalents at the end of the reporting period were HK$25,290,000, up from HK$624,000 at the end of the previous period, reflecting a strong liquidity position [40]. - The Group's current ratio improved to approximately 2.8 as of September 30, 2023, up from approximately 2.5 as of 31 March 2023, indicating a stronger liquidity position [161]. - The Group raised approximately HK$29.8 million from placing activities, with net proceeds allocated for debt repayment, business expansion, and general working capital [167]. - As of September 30, 2023, the Group utilized approximately HK$12.4 million of the net proceeds, leaving a remaining balance of approximately HK$17.4 million [167]. Revenue and Sales - The Group's revenue from external customers for the six months ended 30 September 2023 was HK$35,369,000, a decrease from HK$39,000,000 in the same period of 2022, representing a decline of approximately 9.1% [55]. - Revenue for the Period was approximately HK$43.1 million, representing a slight increase of about 2.7% compared to approximately HK$42.0 million for the same period in 2022, driven by advertising services and sales of new energy products [129]. - The advertising services segment generated revenue of approximately HK$35.4 million, a decrease of about 15.7% from HK$42.0 million in the previous period due to weak market conditions [110]. - Revenue from sales of new energy batteries for the six months ended 30 September 2023 was HK$22,578,000, while advertising service income was HK$18,244,000 [57]. - The new energy battery segment secured contracts for high-power batteries to golf carts in the PRC, recording revenue of approximately HK$2.2 million during the period [113]. - Sales of new energy off-road vehicles generated revenue of approximately HK$2.3 million during the review period [115]. - Zixing Health recorded revenue of approximately HK$3.2 million, driven by increasing demand for health products in the market [120]. Financing Activities - The company reported a net cash generated from financing activities of HK$32,429,000, compared to HK$11,537,000 in the prior year, indicating improved financing capabilities [40]. - The issuance of share capital during the period generated proceeds of HK$29,874,000, contributing positively to the company's financial position [40]. - Outstanding borrowings decreased to approximately HK$20.2 million as of 30 September 2023, down from approximately HK$26.2 million as of 31 March 2023, reflecting a reduction of approximately HK$6.0 million [162]. - The Group's finance costs decreased by approximately 44.3% to approximately HK$1.0 million, down from approximately HK$1.8 million in the Preceding Period, due to a reduction in borrowings from approximately HK$19.3 million to approximately HK$10.7 million [139]. Strategic Focus and Growth Areas - The company is focused on expanding its sales in new energy batteries and off-road vehicles, which are key growth areas for future revenue [42]. - The Group's corporate mission for Weishi New Energy is to become the world's leading supplier of graphene battery fast charging solutions, aligning with its strategic plan to focus on new energy battery business [113]. - The global demand for new energy batteries is accelerating, with China accounting for over 50% of the global electric vehicle market, indicating strong growth opportunities for the Group [174][176]. - The Group plans to actively seek opportunities to integrate its new energy battery and off-road vehicle businesses to reduce costs and enhance competitiveness [152]. Corporate Governance and Compliance - The Group's directors confirm that the information contained in the report is accurate and complete in all material respects, ensuring transparency and accountability [123]. - The company has complied with all code provisions as set out in the Corporate Governance Code for the six months ended September 30, 2023 [198]. Shareholder Information - Basic loss per share attributable to owners of the Company for the six months ended September 30, 2023 was HK$8,215,000, compared to HK$6,737,000 for the same period in 2022 [95]. - The weighted average number of ordinary shares in issue during the six months ended September 30, 2023 was 1,561,864,000, compared to 1,018,971,000 for the same period in 2022 [95]. - Mr. Mou Zhongwei holds 153,500,000 shares, representing 8.36% of the total shares issued as of September 30, 2023 [192]. - The total number of issued shares as of September 30, 2023, is 1,834,136,305 [192]. - The company did not recommend an interim dividend for the six months ended September 30, 2023 [82].

香港交易及結算所有限公司及香港聯合交易所有限公司（「聯交所」）對本公告 之內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示概不就 本公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔 任何責任。 JIADING INTERNATIONAL GROUP HOLDINGS LIMITED 嘉 鼎 國 際 集 團 控 股 有 限 公 司 （於百慕達註冊成立之有限公司） 08153 （股份代號： ） 截 至 二 零 二 三 年 九 月 三 十 日 止 六 個 月 的 中 期 業 績 公 告 嘉 鼎 國 際 集 團 控 股 有 限 公 司（「本 公 司」，連 同 其 子 公 司 統 稱「本 集 團」）董 事 會 （「董事會」）謹此宣佈本集團截至二零二三年九月三十日止六個月的未經審核 中期業績。本公告已載列本公司二零二三年中期報告（「二零二三年中期報告」） 全文，並符合聯交所GEM證券上市規則（「GEM 上市規則」）之相關規定。 載有GEM上市規則規定的資料之二零二三年中期報告印刷本將於適當時候寄 發予本公司股東。 承董事會命 嘉鼎國際集團控股有限公司 主席 牟忠緯 香港，二零二三年十一月十四日 ...

香港交易及結算所有限公司及香港聯合交易所有限公司（「聯交所」）對本公告 之內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示概不就 本公告全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔 任何責任。 本公告僅供參考，並不構成收購、購買或認購本公司證券之邀請或要約。 JIADING INTERNATIONAL GROUP HOLDINGS LIMITED 嘉 鼎 國 際 集 團 控 股 有 限 公 司 （於百慕達註冊成立之有限公司） 08153 （股份代號： ） 截 至 二 零 二 三 年 六 月 三 十 日 止 三 個 月 的 第 一 季 度 業 績 公 告 嘉鼎國際集團控股有限公司（「本公司」，連同其子公司統稱「本集團」）董事會（「董 事會」）謹此宣佈本集團截至二零二三年六月三十日止三個月的未經審核第一 季度業績。本公告已載列本公司二零二三年第一季度報告（「二零二三年第一季 度報告」）全文，並符合聯交所GEM證券上市規則（「GEM 上市規則」）之相關規定。 載有GEM上市規則規定資料之二零二三年第一季度報告印刷本將於適當時候 寄發予本公司股東。 承董事會命 嘉鼎國際集團控股有限公司 主 ...